Sergio Mezzano
- Molecular Biology top 5%
- Nephrology top 0.2%
- Cardiology and Cardiovascular Medicine top 2%
- Immunology top 5%
- Endocrinology, Diabetes and Metabolism top 1%
- Co-authors
- Marta Ruiz‐OrtegaJesús EgidoLeopoldo ArdilesVanesa EstebanAlejandra DroguettJ. EgidoÓscar LorenzoAlberto Ortíz
- Topics
- Renal Diseases and Glomerulopathies (29 papers)Chronic Kidney Disease and Diabetes (20 papers)Connective Tissue Growth Factor Research (15 papers)
- Partner nations
- ChileSpainUnited States
In The Last Decade
Sergio Mezzano
130 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 2.2k
- Nephrology 2.0k
- Cardiology and Cardiovascular Medicine 1.3k
- Immunology 888
- Endocrinology, Diabetes and Metabolism 881
Countries citing papers authored by Sergio Mezzano
This map shows the geographic impact of Sergio Mezzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Mezzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Mezzano more than expected).
Fields of papers citing papers by Sergio Mezzano
This network shows the impact of papers produced by Sergio Mezzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Mezzano. The network helps show where Sergio Mezzano may publish in the future.
Co-authorship network of co-authors of Sergio Mezzano
This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Mezzano. A scholar is included among the top collaborators of Sergio Mezzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Mezzano. Sergio Mezzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 14 | |
| 3 | Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunitiesbreakdown → | 251 |
| 4 | Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathybreakdown → | 232 |
| 5 | 107 | |
| 6 | 34 | |
| 7 | 59 | |
| 8 | 55 | |
| 9 | 56 | |
| 10 | El factor de crecimiento de tejido conectivo (CTGF): factor clave en el inicio y la progresión del daño renal | 16 |
| 11 | 109 | |
| 12 | 95 | |
| 13 | 65 | |
| 14 | 1 | |
| 15 | 345 | |
| 16 | 8 | |
| 17 | 114 | |
| 18 | 63 | |
| 19 | 10 | |
| 20 | 13 |
About Sergio Mezzano
Sergio Mezzano is a scholar working on Nephrology, Transplantation and Immunology, having authored 131 papers that have together received 6.2k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (29 papers), Chronic Kidney Disease and Diabetes (20 papers) and Connective Tissue Growth Factor Research (15 papers). The work is most often cited by research in Nephrology (2.0k citations), Cardiology and Cardiovascular Medicine (1.3k citations) and Clinical Biochemistry (361 citations). Sergio Mezzano has collaborated with scholars based in Chile, Spain and United States. Frequent co-authors include Marta Ruiz‐Ortega, Jesús Egido, Leopoldo Ardiles, Vanesa Esteban, Alejandra Droguett, J. Egido, Óscar Lorenzo, Alberto Ortíz, Mónica Rupérez and M. Eugenia Burgos. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.